Pharma Times

OCTOBER 1, 2021

The European Patent Office (EPO) has granted a patent to specialist pharmaceutical company, N4 Pharma, for its Nuvec cancer treatment and vaccine delivery system.

Vaccines 123

Vaccines Pharmaceutical Companies Pharmaceutical Companies 123

pharmaphorum

FEBRUARY 9, 2022

In this article, Ben Hargreaves looks into the promise of cancer vaccines and how this treatment modality may offer advantages over existing immunotherapies in the oncology sector. The oncology segment has been recognised as one of the most productive areas for pharmaceutical companies to focus their R&D investment.

Vaccines 134

Vaccines Immunity Immunization Labelling 134

The Guardian - Pharmaceutical Industry

AUGUST 14, 2024

Chancellor reportedly seeking to cut £20m from the £65m promised by Hunt to Merseyside manufacturing plant Business live – latest updates A £450m plan to expand an AstraZeneca vaccine-manufacturing site in Merseyside has suffered a blow after it emerged the government plans to cut some of the funding for the scheme. Continue reading.

Vaccines 99

Vaccines Pharmaceutical Companies Pharmaceutical Companies 99

pharmaphorum

SEPTEMBER 8, 2020

An EU consumer body has urged the European Commission to keep compensation measures in place for people who might be harmed in COVID-19 vaccine trials, responding to reports that the drug industry is lobbying to reduce liability. The BEUC is adamant that relaxing consumer protections even in such exceptional circumstances is a bad idea.

Vaccines 119

Vaccines Pharmaceutical Companies Pharmaceutical Companies 119

Express Pharma

JUNE 12, 2024

Moderna has announced positive Phase III data for its COVID-19/influenza combination vaccine, mRNA-1083. Stephanie Kurdach, Infectious Disease Analyst at GlobalData, comments, “Moderna’s mRNA-1083 combines the mRNA-1010 seasonal influenza vaccine candidate with the mRNA-1283 next-generation Covid-19 vaccine candidate.

Vaccines 104

Vaccines Adverse Reactions Immunity Immunization 104

European Pharmaceutical Review

OCTOBER 6, 2023

Positive interim results from Moderna’s Phase I/II trial of mRNA-1083 , an investigational vaccine designed to immunise against both influenza and COVID-19, have been released. There are several benefits of the combination vaccine as a preventative measure against these respiratory conditions, according to the pharmaceutical company.

Vaccines 105

Vaccines Pharmaceutical Companies Pharmaceutical Companies 105

pharmaphorum

JANUARY 31, 2022

It is becoming increasingly important for people all over the world to understand the importance of vaccines and to have access to the vaccines they need – especially with digital innovation driving new vaccine development. Pfizer’s Josh Raysman, Saad Saeed, and Shanaya Deboo discuss vaccine awareness, access, and innovation.

Vaccines 97

Vaccines Pharmaceutical Companies Pharmaceutical Companies Drug Development 97

The Pharmacist

NOVEMBER 1, 2023

Ensuring good access and information around vaccinations is ‘key’ to tackling health inequalities, director of market access and policy affairs at Moderna told delegates at a Westminster Health Forum this week.

Vaccines 84

Vaccines Pharmaceutical Companies Pharmaceutical Companies 84

PharmaTech

FEBRUARY 2, 2023

The COVID-19 pandemic has led to many changes and shifts in the pharmaceutical industry, specifically with how pharmaceutical companies develop vaccines.

Vaccines 75

Vaccines Pharmaceutical Companies Pharmaceutical Companies 75

pharmaphorum

DECEMBER 16, 2022

Ben Hargreaves discovers why some have referred to the distribution of COVID-19 vaccines and treatments as a form of apartheid. Vaccine access for a price. Tendayi Achium, labelled the response by the global community as a form of “vaccine apartheid,” a suggestion echoed by the organisation’s director general.

Vaccines 96

Vaccines Pharmaceutical Manufacturing Labelling Compounding 96

The Guardian - Pharmaceutical Industry

JANUARY 27, 2025

Collaboration over at least three years aims to help understand how pre-cancerous cells develop Business live latest updates GSK has said it will spend 50m on a project with the University of Oxford to investigate whether vaccines could be used to prevent some cancers. Continue reading.

Vaccines 71

Vaccines Pharmaceutical Companies Pharmaceutical Companies 71

Pharmafile

MAY 9, 2024

UK-based pharmaceutical company AstraZeneca has announced that is it voluntarily withdrawing its COVID-19 vaccine Vaxzevria due to a drop in global demand. The withdrawal also comes after AstraZeneca admitted in court documents that the vaccine can cause thrombosis with thrombocytopenia syndrome (TTS).

Vaccines 59

Vaccines Documentation Pharmaceutical Companies Pharmaceutical Companies 59

NY Times

APRIL 27, 2021

It feels very American to turn the vaccine rollout into a branding spectacle rooted in the worship of pharmaceutical companies.

Vaccines 62

Vaccines Pharmaceutical Companies Pharmaceutical Companies Immunity 62

European Pharmaceutical Review

AUGUST 31, 2023

Even with extremely rapid vaccine development, limitations in production capabilities can have real-life implications. This has led pharmaceutical equipment manufacturers to react quickly, while maintaining due levels of diligence and social responsibility.

Vaccines 104

Vaccines Packaging Pharmaceutical Companies Pharmaceutical Companies 104

NY Times

OCTOBER 13, 2020

Big profits beckon for pharmaceutical companies, which are already using their work on vaccines to fight efforts in Washington to curb drug prices.

Vaccines 61

Vaccines Drug Pricing Pharmaceutical Companies Pharmaceutical Companies 61

NY Times

JANUARY 7, 2021

Readers discuss an Op-Ed that argued that pharmaceutical companies don’t deserve the public relations lift from the rapid vaccine development.

Vaccines 52

Vaccines Pharmaceutical Companies Pharmaceutical Companies Immunity 52

PharmaTech

FEBRUARY 7, 2023

The COVID-19 pandemic has led to many changes and shifts in the pharmaceutical industry, specifically with how pharmaceutical companies develop vaccines.

Vaccines 52

Vaccines Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

APRIL 25, 2023

As the prophylactic landscape for malaria has changed in recent years with vaccine approvals, major issues still remain with ensuring access in remote communities. However, making sure the vaccine reaches everyone can be challenging due to the storage requirements. The Mosquirix vaccine contains two vials.

Vaccines 69

Vaccines Communication Pharmaceutical Companies Pharmaceutical Companies 69

Pharma Mirror

SEPTEMBER 11, 2022

Bandung, W Java, Indonesia, PT Bio Farma, the holding company for state-owned pharmaceutical companies in Indonesia, announced a new milestone in the manufacturing of IndoVac, a Covid-19 vaccine brand it has developed since November 2021.

Vaccines 52

Vaccines Pharmaceutical Companies Pharmaceutical Companies 52

European Pharmaceutical Review

FEBRUARY 10, 2025

AstraZeneca has scrapped its planned 450 million expansion of a vaccine manufacturing facility in Liverpool, UK, citing economic factors and reduced government funding. The post AstraZeneca cancels 450m Liverpool vaccine facility expansion appeared first on European Pharmaceutical Review.

Vaccines 52

Vaccines Pharmaceutical Companies Pharmaceutical Companies Pharmaceutical Manufacturing 52

pharmaphorum

OCTOBER 21, 2022

The UK company reveals the results from a partner-led survey to discover the rates of vaccination for adults, why levels are lower than expected, and what can be done to improve this. The result of the improving knowledge of vaccines’ role in society initially led to a rise in interest in receiving a COVID-19 vaccine.

Vaccines 98

Vaccines Immunity Immunization Compounding 98

pharmaphorum

APRIL 8, 2020

This pharmaphorum webinar will take place on 8th April and comes as the COVID-19 outbreak has exposed the challenges pharmaceutical companies face as they race to develop a coronavirus vaccine. So, what is technology’s role in supporting the faster evaluation of vaccines?

Vaccines 52

Vaccines Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

FEBRUARY 15, 2023

In the last three years alone, there have been over 633,000 patents filed and granted in the pharmaceutical industry, according to GlobalData’s report on Innovation in Pharmaceuticals: Coronavirus vaccine components. The vaccine also contains other inactive ingredients such as cholesterol.

Vaccines 52

Vaccines Immunity Immunization Pharmaceutical Companies 52

Pharmaceutical Technology

FEBRUARY 15, 2023

In the last three years alone, there have been over 633,000 patents filed and granted in the pharmaceutical industry, according to GlobalData’s report on Innovation in Pharmaceuticals: Flavivirus vaccine components. Sanofi is one of the leading patent filers for Flavivirus vaccine components.

Vaccines 52

Vaccines Immunity Immunization Pharmaceutical Companies 52

Pharmaceutical Technology

MARCH 9, 2023

In the last three years alone, there have been over 633,000 patents filed and granted in the pharmaceutical industry, according to GlobalData’s report on Innovation in Pharmaceuticals: Multivalent veterinary vaccines. However, not all innovations are equal and nor do they follow a constant upward trend.

Vaccines 52

Vaccines Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Business Review

APRIL 9, 2023

Located at the TÜBITAK MAM Gebze campus in Kocaeli province close to Istanbul, the MEDIBIYO facility can generate biotechnological drugs and vaccines that align with good manufacturing practice (GMP) standards, stated the Turkish publication. MEDIBIYO is expected to begin operations to meet demands of the pharmaceutical companies.

Vaccines 52

Vaccines Biosimilars Pharmaceutical Companies Pharmaceutical Companies 52

Pharma Leaders

APRIL 9, 2023

Marmara Research Center (MAM) and The Scientific and Technological Research Council of Türkiye (TÜBITAK) have commenced Medical Biotechnology Research Center (MEDIBIYO) for the production of drugs and vaccines on a pilot scale, reported Daily Sabah. MEDIBIYO is expected to begin operations to meet demands of the pharmaceutical companies.

Vaccines 52

Vaccines Biosimilars Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

APRIL 21, 2023

US-based biopharmaceutical company Blue Water Vaccines has signed an asset purchase agreement with Veru to buy its Entadfi (finasteride and tadalafil) capsules business, for a total consideration of $100m. The company plans to optimise strategies around sales, distribution and marketing of the drug to increase its access.

Vaccines 52

Vaccines Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

NOVEMBER 15, 2022

When it comes to vaccines and other high-value biologics, it is essential that effective formulations go hand in hand with safe delivery. This also has clear advantages in healthcare settings, particularly when it comes to vaccines. In general, a prefilled syringe is clearly preferred for vaccines.”. A new challenge .

Packaging 52

Packaging Vaccines Dosage Compounding 52

STAT

FEBRUARY 8, 2024

A road test for fresh pharma CEOs A lot can change in five years — including the leadership of the three major pharmaceutical companies that will be testifying before Sen.   Sign up here  to receive it in your inbox on Tuesdays and Thursdays. Bernie Sanders’ HELP Committee today. Read the rest…

Pharmaceutical Companies 264

Pharmaceutical Companies Pharmaceutical Companies Drug Pricing Vaccines 264

STAT

APRIL 23, 2025

… Four months ago, a small pharmaceuticals company bought a medicine used to combat a rare growth disorder in children and quickly raised the list price by 150% , STAT says. European pharmaceutical bosses have called on the European Union to increase drug prices toward the much higher levels paid by the U.S.,

Compounding 176

Compounding Generic Medicine Pharmaceutical Companies Pharmaceutical Companies 176

NY Times

JUNE 2, 2021

We need more vaccines, fast. Is forcing pharmaceutical companies to share their intellectual property the answer?

Vaccines 55

Vaccines Pharmaceutical Companies Pharmaceutical Companies Immunity 55

Express Pharma

NOVEMBER 15, 2024

In the last few years, we have witnessed the pharmaceutical industry in its most intense form. With the onset of the COVID-19 pandemic, they have spared no effort in providing crucial vaccinations to protect the world. Automating these processes can be critical in helping pharmaceutical companies manage their cloud infrastructure.

Pharmaceutical Companies 102

Pharmaceutical Companies Pharmaceutical Companies Vaccines 102

STAT

JUNE 22, 2023

Hope you have a smashing day and, of course, do stay in touch … Leaders of European pharmaceutical companies argued that a proposed overhaul of European Union policies could render the industry less competitive, the latest step in their opposition to legislation that could shorten exclusivity periods for selling drugs, STAT writes.

Diabetes 234

Diabetes Pharmaceutical Companies Pharmaceutical Companies Vaccines 234

pharmaphorum

SEPTEMBER 6, 2022

The NHS is moving to the next phase of its SARS-CoV-2 vaccination programme, following health secretary Steve Barclay’s acceptance of advice from the Joint Committee on Vaccination and Immunisation (JCVI) to go ahead with rollout of Pfizer’s bivalent 30mg booster shot this week. million)” during the first year of vaccinations.

Vaccines 98

Vaccines Pharmaceutical Companies Pharmaceutical Companies 98

STAT

MAY 20, 2024

For more than a year, Sanders has used his perch atop the Senate health committee to haul the CEOs of pharmaceutical companies that make insulin, vaccines, and more before the panel with progressively more ambitious demands related to their pricing.

Diabetes 342

Diabetes Pharmaceutical Companies Pharmaceutical Companies Vaccines 342

pharmaphorum

JANUARY 16, 2023

With demand for its COVID-19 vaccine decreasing, Johnson & Johnson (J&J) has begun scaling back production of the shots. However, Merck only produced the vaccine at one of its plants and was not involved in the commercial, more complex part of the manufacturing process at another plant, according to sources close to the matter.

Vaccines 111

Vaccines Pharmaceutical Companies Pharmaceutical Companies 111